CereVasc

About:

CereVasc is a medical device company focused on improving the treatment of patients with hydrocephalus.

Website: https://cerevasc.com/

Top Investors: Perceptive Advisors, Bain Capital Life Sciences, ATON Partners

Description:

CereVasc is a medical device company focused on the development of novel, minimally invasive treatments for patients with neurological diseases. Current treatment of these patients requires an invasive, neurosurgical procedure with a documented rate of success well below the success rate for other neurosurgical interventions. The eShunt System has the potential to significantly improve patient outcomes and substantially decrease the overall cost of surgical treatment of this life-threatening condition.

Total Funding Amount:

$114M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Auburndale, Massachusetts, United States

Founded Date:

2014-01-01

Founders:

Adel Malek, Carl Heilman, Daniel Levangie, Patrick Sullivan

Number of Employees:

11-50

Last Funding Date:

2024-05-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai